Bayer (BAYN) Stock Forecast & Price Target

Compare

822 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BAYN Analyst Ratings

Moderate Buy

8 Buy

5 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Bayer

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BAYN Stock 12 Month Forecast

Average Price Target

€38.46

▼(-14.90% Downside)

Based on 13 Wall Street analysts offering 12 month price targets for Bayer in the last 3 months. The average price target is €38.46 with a high forecast of €53.00 and a low forecast of €23.00. The average price target represents a -14.90% change from the last price of €45.19.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"18":"€18","27":"€27","36":"€36","45":"€45","54":"€54"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":53,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€53.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":38.45833333333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€38.46</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€23.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[18,27,36,45,54],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.01,38.239999999999995,39.47,40.699999999999996,41.93,43.16,44.39,45.62,46.85,48.08,49.31,50.54,51.769999999999996,{"y":53,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.01,37.12141025641026,37.23282051282051,37.34423076923077,37.45564102564102,37.56705128205128,37.678461538461534,37.78987179487179,37.901282051282045,38.012692307692305,38.12410256410256,38.23551282051282,38.34692307692307,{"y":38.45833333333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.01,35.93230769230769,34.854615384615386,33.776923076923076,32.699230769230766,31.62153846153846,30.543846153846154,29.466153846153844,28.388461538461538,27.310769230769232,26.233076923076922,25.155384615384616,24.07769230769231,{"y":23,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":19.221,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.536,"date":1738368000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":22.601,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.208,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.03,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.14,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.46,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.12,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.86,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.64,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.95,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.47,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.01,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€53.00

Average Price Target€38.46

Lowest Price Target€23.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Christian Faitz

Kepler Capital

€42→€53

Buy

17.28%

Upside

Reiterated

01/26/26

Kepler Capital Remains a Buy on Bayer (0P6S)

Richard Vosser

J.P. Morgan

€50

Buy

10.64%

Upside

Reiterated

01/23/26

J.P. Morgan Reaffirms Their Buy Rating on Bayer (0P6S)

Charles Pitman CFA

Barclays

€45→€50

Buy

10.64%

Upside

Reiterated

01/20/26

Barclays Sticks to Its Buy Rating for Bayer (0P6S)

Matthew Weston

UBS

€32

Hold

-29.19%

Downside

Reiterated

01/20/26

UBS Keeps Their Hold Rating on Bayer (0P6S)

Peter Spengler

DZ BANK AG

Buy

―

Reiterated

01/19/26

DZ BANK AG Sticks to Its Buy Rating for Bayer (0P6S)

Chris Counihan

Jefferies

€25

Hold

-44.68%

Downside

Reiterated

01/19/26

Jefferies Sticks to Their Hold Rating for Bayer (0P6S)

James Quigley

Goldman Sachs

€42.5

Buy

-5.95%

Downside

Reiterated

01/19/26

Goldman Sachs Sticks to Their Buy Rating for Bayer (0P6S)

Sebastian Bray

Berenberg Bank

€30.4→€41

Hold

-9.27%

Downside

Reiterated

12/12/25

Bayer (0P6S) Gets a Hold from Berenberg Bank

Rajesh Kumar

HSBC

€34→€40

Buy

-11.48%

Downside

Reiterated

12/10/25

Bayer price target raised to EUR 40 from EUR 34 at HSBCBayer price target raised to EUR 40 from EUR 34 at HSBC

Thibault Boutherin

Morgan Stanley

€29→€40

Buy

-11.48%

Downside

Upgraded

12/03/25

Bayer upgraded to Overweight from Equal Weight at Morgan StanleyBayer upgraded to Overweight from Equal Weight at Morgan Stanley

Sachin Jain

Bank of America Securities

€35

Buy

-22.55%

Downside

Reiterated

12/02/25

Bank of America Securities Keeps Their Buy Rating on Bayer (0P6S)

Florent Cespedes

Bernstein

€30

Hold

-33.61%

Downside

Reiterated

11/24/25

Bernstein Sticks to Its Hold Rating for Bayer (0P6S)

Falko Friedrichs

Deutsche Bank

€23

Hold

-49.10%

Downside

Reiterated

11/12/25

Deutsche Bank Reaffirms Their Hold Rating on Bayer (0P6S)

Andreas Heine

Stifel Nicolaus

€28

Hold

-38.04%

Downside

Reiterated

03/05/25

Bayer's Financial Challenges and Mixed Divisional Performance Lead to Hold Rating

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Christian Faitz

Kepler Capital

€42→€53

Buy

17.28%

Upside

Reiterated

01/26/26

Kepler Capital Remains a Buy on Bayer (0P6S)

Richard Vosser

J.P. Morgan

€50

Buy

10.64%

Upside

Reiterated

01/23/26

J.P. Morgan Reaffirms Their Buy Rating on Bayer (0P6S)

Charles Pitman CFA

Barclays

€45→€50

Buy

10.64%

Upside

Reiterated

01/20/26

Barclays Sticks to Its Buy Rating for Bayer (0P6S)

Matthew Weston

UBS

€32

Hold

-29.19%

Downside

Reiterated

01/20/26

UBS Keeps Their Hold Rating on Bayer (0P6S)

Peter Spengler

DZ BANK AG

Buy

―

Reiterated

01/19/26

DZ BANK AG Sticks to Its Buy Rating for Bayer (0P6S)

Chris Counihan

Jefferies

€25

Hold

-44.68%

Downside

Reiterated

01/19/26

Jefferies Sticks to Their Hold Rating for Bayer (0P6S)

James Quigley

Goldman Sachs

€42.5

Buy

-5.95%

Downside

Reiterated

01/19/26

Goldman Sachs Sticks to Their Buy Rating for Bayer (0P6S)

Sebastian Bray

Berenberg Bank

€30.4→€41

Hold

-9.27%

Downside

Reiterated

12/12/25

Bayer (0P6S) Gets a Hold from Berenberg Bank

Rajesh Kumar

HSBC

€34→€40

Buy

-11.48%

Downside

Reiterated

12/10/25

Bayer price target raised to EUR 40 from EUR 34 at HSBCBayer price target raised to EUR 40 from EUR 34 at HSBC

Thibault Boutherin

Morgan Stanley

€29→€40

Buy

-11.48%

Downside

Upgraded

12/03/25

Bayer upgraded to Overweight from Equal Weight at Morgan StanleyBayer upgraded to Overweight from Equal Weight at Morgan Stanley

Sachin Jain

Bank of America Securities

€35

Buy

-22.55%

Downside

Reiterated

12/02/25

Bank of America Securities Keeps Their Buy Rating on Bayer (0P6S)

Florent Cespedes

Bernstein

€30

Hold

-33.61%

Downside

Reiterated

11/24/25

Bernstein Sticks to Its Hold Rating for Bayer (0P6S)

Falko Friedrichs

Deutsche Bank

€23

Hold

-49.10%

Downside

Reiterated

11/12/25

Deutsche Bank Reaffirms Their Hold Rating on Bayer (0P6S)

Andreas Heine

Stifel Nicolaus

€28

Hold

-38.04%

Downside

Reiterated

03/05/25

Bayer's Financial Challenges and Mixed Divisional Performance Lead to Hold Rating

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bayer

3 Months

xxx

Success Rate

17/23 ratings generated profit

Average Return

+5.40%

reiterated a xxx

rating 11 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 73.91% of your transactions generating a profit, with an average return of +5.40% per trade.

1 Year

James QuigleyGoldman Sachs

Success Rate

17/23 ratings generated profit

Average Return

+13.55%

reiterated a buy rating 11 days ago

Copying James Quigley's trades and holding each position for 1 Year would result in 73.91% of your transactions generating a profit, with an average return of +13.55% per trade.

2 Years

xxx

Success Rate

17/23 ratings generated profit

Average Return

+11.30%

reiterated a xxx

rating 11 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 73.91% of your transactions generating a profit, with an average return of +11.30% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BAYN Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BAYN has received 23 Buy Ratings, 18 Hold Ratings, and 0 Sell Ratings. BAYN average Analyst price target in the past 3 months is 38.46.

Each month's total comprises the sum of three months' worth of ratings.

BAYN Financial Forecast

BAYN Earnings Forecast

Next quarter’s earnings estimate for BAYN is €0.35 with a range of -€0.25 to €0.54. The previous quarter’s EPS was €0.57. BAYN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year BAYN has Performed in-line its overall industry.

BAYN Sales Forecast

Next quarter’s sales forecast for BAYN is €11.14B with a range of €10.65B to €11.41B. The previous quarter’s sales results were €9.66B. BAYN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year BAYN has Performed in-line its overall industry.

BAYN Stock Forecast FAQ

What is DE:BAYN’s average 12-month price target, according to analysts?

Based on analyst ratings, Bayer’s 12-month average price target is 38.46.

What is DE:BAYN’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for DE:BAYN, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is DE:BAYN a Buy, Sell or Hold?

Bayer has a consensus rating of Moderate Buy which is based on 8 buy ratings, 5 hold ratings and 0 sell ratings.

What is Bayer’s price target?

The average price target for Bayer is 38.46. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is €53.00 ,the lowest forecast is €23.00. The average price target represents -14.90% Decrease from the current price of €45.19.

What do analysts say about Bayer?

Bayer’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of DE:BAYN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Bayer (BAYN) Stock Forecast & Price Target

BAYN Analyst Ratings

BAYN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Bayer

BAYN Analyst Recommendation Trends

BAYN Financial Forecast

BAYN Earnings Forecast

BAYN Sales Forecast

BAYN Stock Forecast FAQ

Detailed List of Analyst Forecasts